Nom du produit:1-(2-allyloxy-5-bromo-phenyl)hexahydropyrimidine-2,4-dione
IUPAC Name:1-[5-bromo-2-(prop-2-en-1-yloxy)phenyl]-1,3-diazinane-2,4-dione
- CAS：2703772-19-2
- Formule moléculaire：C13H13BrN2O3
- Pureté：95%
- Numéro de catalogue：CM1076088
- Poids moléculaire：325.16
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2703772-19-2
- Formule moléculaire:C13H13BrN2O3
- Point de fusion:-
- Code SMILES:BrC1=CC(N2CCC(=O)NC2=O)=C(OCC=C)C=C1
- Densité:
- Numéro de catalogue:CM1076088
- Poids moléculaire:325.16
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- PROTAC-E3 Ligase Ligands
- Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
- PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
- Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
- PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.
Recherche 
+86 21 5895 0110 
